At the 4th Annual Clinical Trial Innovation Summit hosted at Genentech on October 22, 2024, Dr. Krista Leonard-Corzo, a lead research scientist at VivoSense, highlighted the importance of prioritizing patient perspectives when incorporating digital health technologies in clinical trials. Her presentation focused on two key areas: identifying meaningful aspects of health and returning individual study results back to participants, both of which address common challenges sponsors face—determining what to measure and improving participant compliance with digital health technologies.
Dr. Leonard-Corzo discussed how VivoSense begins by identifying “meaningful aspects of health” to ensure that digital measures focus on what truly matters to patients. This involves understanding which symptoms or health impacts patients prioritize and integrating these insights into trial design, creating a more relevant and motivating experience for participants.
Complementing this, VivoSense’s approach to returning individual study results directly engages patients by providing personalized summaries of study findings. By co-creating these reports with participants and refining them based on participant feedback, VivoSense has developed a method to share individual study results that fosters transparency, builds trust, and enhances patient engagement. Participants not only appreciate receiving data that helps them manage their health, but they also feel more valued and connected to the trial process, which supports long-term compliance.
As evidence of this theme, Dr. Leonard-Corzo & Dr. Jennifer Blankenship from VivoSense recently sat down with a patient advocate to discuss this very topic.
Watch the Video Here
Through these two patient-centered approaches—measuring meaningful health aspects and delivering study results—VivoSense is advancing clinical trials by prioritizing the patient perspective. By addressing what to measure and ensuring compliance through the patient voice, VivoSense is empowering participants and paving the way for more effective, impactful clinical research.
Organizations interested in strengthening participant engagement and designing trials that resonate with patients are encouraged to reach out to VivoSense to explore these innovative methods.